Dr Reddys Laboratories (RDY) Income from Continuing Operations (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Income from Continuing Operations of 170000000.0 for Q2 2023, down 1.16% quarter-over-quarter from 172000000.0 in Q1 2023.
Dr Reddys Laboratories (RDY) Income from Continuing Operations (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 170000000.0 for Q2 2023.
- In Q2 2023, Income from Continuing Operations changed N/A year-over-year to 170000000.0; the TTM figure through Jun 2023 stood at 459000152.0 (changed N/A YoY), while the FY2026 annual figure was 452000000.0, down 32.64% from the prior year.
- Income from Continuing Operations for Q2 2023 stood at 170000000.0, down from 172000000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 172000000.0 in Q1 2023, with the low at 108000000.0 in Q3 2020.
- The 5-year median for Income from Continuing Operations is 110500000.0 (2019), against an average of 90250012.67.
- The sharpest annual moves came in 2019 and 2020: Income from Continuing Operations surged 131.82% in 2019, then sank 258.82% in 2020.
- Dr Reddys Laboratories' Income from Continuing Operations stood at 68000000.0 in 2019, then tumbled by 258.82% to 108000000.0 in 2020, then surged by 224.07% to 134000000.0 in 2021, then slipped by 12.69% to 117000000.0 in 2022, then surged by 45.3% to 170000000.0 in 2023.
- Business Quant data shows RDY's Income from Continuing Operations at 170000000.0 in Q2 2023, 172000000.0 in Q1 2023, and 117000000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.86 Bn | 11.33 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.13 Bn | 7.47 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 170.00 Mn |
| Mar 31, 2023 | 172.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 |
| Jun 30, 2021 | 134.00 Mn |
| Mar 31, 2021 | 77.00 Mn |
| Sep 30, 2020 | -108.00 Mn |
| Jun 30, 2020 | 104.00 Mn |
| Mar 31, 2020 | 79.00 Mn |
| Sep 30, 2019 | 68.00 Mn |
| Jun 30, 2019 | 153.00 Mn |
| Mar 31, 2019 | 117.00 Mn |
| Dec 31, 2018 | 63.00 Mn |
| Sep 30, 2018 | 70.00 Mn |
| Jun 30, 2018 | 66.00 Mn |
| Mar 31, 2018 | 63.00 Mn |
| Dec 31, 2017 | 44.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Dec 31, 2016 | 22.00 Mn |
| Sep 30, 2016 | 86.00 Mn |